SRSF1 and acute myeloid leukemia: In subsequent analysis, we also observed that most of the up-regulated SFs, such as HNRNPAB, HNRNPR, SRSF1, SRSF6 and SRSF11, were significantly associated with poor prognosis in patients with AML.